{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:22:42Z","timestamp":1792282962141,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2999,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.virol.2005.02.020","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T07:46:04Z","timestamp":1113032764000},"page":"70-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Characterization of neutralizing antibodies to West Nile virus"],"prefix":"10.1016","volume":"336","author":[{"given":"Melissa D.","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri L.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget A.","family":"Puffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam M.","family":"Murtadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hoxie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Doms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2005.02.020_bib1","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.4049\/jimmunol.163.12.6756","article-title":"A DNA immunization model study with constructs expressing the Tick-Borne Encephalitis virus envelope protein E in different physical forms","volume":"163","author":"Aberle","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.02.020_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0042-6822(95)80018-2","article-title":"Glycosylation and antigenic variation among Kunjin virus isolates","volume":"206","author":"Adams","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.02.020_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/376871","article-title":"Human immunoglobulin as a treatment for West Nile virus infection","volume":"188","author":"Agrawal","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2005.02.020_bib4","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/jvi.69.9.5816-5820.1995","article-title":"Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form","volume":"69","author":"Allison","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/jvi.69.2.695-700.1995","article-title":"Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH","volume":"69","author":"Allison","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib6","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1749-6632.2001.tb02702.x","article-title":"Current status of flavivirus vaccines","volume":"951","author":"Barrett","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.virol.2005.02.020_bib8","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1128\/JVI.76.24.13097-13100.2002","article-title":"Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein","volume":"76","author":"Beasley","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"Pt. 9","key":"10.1016\/j.virol.2005.02.020_bib10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1099\/0022-1317-78-9-2293","article-title":"Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses","volume":"78","author":"Berthet","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01311025","article-title":"Antigenic analysis of West Nile virus strains using monoclonal antibodies","volume":"99","author":"Besselaar","year":"1988","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib12","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/JVI.75.8.4002-4007.2001","article-title":"Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein","volume":"75","author":"Bhardwaj","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.emboj.7600064","article-title":"Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation","volume":"23","author":"Bressanelli","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2005.02.020_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.1998.58.389","article-title":"Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E","volume":"58","author":"Butrapet","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2005.02.020_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/infdis\/130.6.634","article-title":"Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors","volume":"130","author":"Camenga","year":"1974","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2005.02.020_bib16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1099\/0022-1317-79-10-2375","article-title":"West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness","volume":"79","author":"Chambers","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib71","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/JVI.74.9.4244-4252.2000","article-title":"A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice","volume":"74","author":"Chang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib17","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib18","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib19","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib20","first-page":"16.17.11","article-title":"Generation of recombinant vaccinia viruses","volume":"vol. 2","author":"Earl","year":"1993"},{"key":"10.1016\/j.virol.2005.02.020_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3201\/eid0704.017408","article-title":"Partial genetic characterization of West Nile virus strains, New York State, 2000","volume":"7","author":"Ebel","year":"2001","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.virol.2005.02.020_bib22","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/321244a0","article-title":"A new mechanism for the neutralization of enveloped viruses by antiviral antibody","volume":"321","author":"Gollins","year":"1986","journal-title":"Nature"},{"issue":"Pt. 6","key":"10.1016\/j.virol.2005.02.020_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1099\/0022-1317-72-6-1323","article-title":"Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions","volume":"72","author":"Guirakhoo","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01309481","article-title":"Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice","volume":"137","author":"Halevy","year":"1994","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib26","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/377172","article-title":"The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis","volume":"37","author":"Haley","year":"2003","journal-title":"Clin. Infect Dis."},{"issue":"Pt. 1","key":"10.1016\/j.virol.2005.02.020_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/icb.1991.7","article-title":"Monoclonal antibodies to Kunjin and Kokobera viruses","volume":"69","author":"Hall","year":"1991","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2005.02.020_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1399-3062.2002.01014.x","article-title":"Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis","volume":"4","author":"Hamdan","year":"2002","journal-title":"Transpl. Infect Dis."},{"key":"10.1016\/j.virol.2005.02.020_bib29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jmv.1890450417","article-title":"Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2","volume":"45","author":"He","year":"1995","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0065-3527(00)55005-2","article-title":"Structures and mechanisms in flavivirus fusion","volume":"55","author":"Heinz","year":"2000","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2005.02.020_bib31","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/jvi.65.10.5579-5583.1991","article-title":"The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization","volume":"65","author":"Heinz","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib32","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/0264-410X(95)00133-L","article-title":"Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis","volume":"13","author":"Heinz","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.02.020_bib33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","article-title":"An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells","volume":"78","author":"Hung","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00346-9","article-title":"A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen","volume":"97","author":"Hunt","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2005.02.020_bib35","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1099\/0022-1317-83-9-2091","article-title":"Occupancy and mechanism in antibody-mediated neutralization of animal viruses","volume":"83","author":"Klasse","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib36","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0264-410X(01)00446-7","article-title":"Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine","volume":"20","author":"Konishi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.02.020_bib37","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/jvi.67.3.1672-1675.1993","article-title":"Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein","volume":"67","author":"Konishi","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/0042-6822(92)90526-U","article-title":"Mice immunized with a subviral particle containing the Japanese encephalitis virus prM\/M and E proteins are protected from lethal JEV infection","volume":"188","author":"Konishi","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.02.020_bib39","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1128\/JVI.75.5.2204-2212.2001","article-title":"Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles","volume":"75","author":"Konishi","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib40","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00705-002-0809-3","article-title":"Murray Valley encephalitis virus recombinant subviral particles protect mice from lethal challenge with virulent wild-type virus","volume":"147","author":"Kroeger","year":"2002","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.virol.2005.02.020_bib42","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.02.020_bib43","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1128\/JVI.76.11.5480-5491.2002","article-title":"Folding and dimerization of Tick-Borne Encephalitis virus envelope proteins prM and E in the endoplasmic reticulum","volume":"76","author":"Lorenz","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib44","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1128\/JVI.75.22.10787-10799.2001","article-title":"Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively","volume":"75","author":"Mackenzie","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.02.020_bib46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0923-2516(90)90085-W","article-title":"Comparative analysis of West Nile virus strains isolated from human and animal hosts using monoclonal antibodies and cDNA restriction digest profiles","volume":"141","author":"Mathiot","year":"1990","journal-title":"Res. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib47","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2005.02.020_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virol.2005.02.020_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1089316","article-title":"Structure of West Nile virus","volume":"302","author":"Mukhopadhyay","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2005.02.020_bib50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2003.08.001","article-title":"Vaccines and animal models for arboviral encephalitides","volume":"60","author":"Nalca","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virol.2005.02.020_bib51","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.virol.2005.02.020_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/0022-1317-58-2-283","article-title":"Monoclonal antibodies against the flavivirus West Nile","volume":"58","author":"Peiris","year":"1982","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib53","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0264-410X(99)00570-8","article-title":"Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein","volume":"18","author":"Raviprakash","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2005.02.020_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.virol.2005.02.020_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2005.02.020_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.1998.9200","article-title":"Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica","volume":"246","author":"Roehrig","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.02.020_bib57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0968-0004(00)89080-5","article-title":"RASMOL: biomolecular graphics for all","volume":"20","author":"Sayle","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.virol.2005.02.020_bib58","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/jvi.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3201\/eid0704.017432","article-title":"Treatment of West Nile virus encephalitis with intravenous immunoglobulin","volume":"7","author":"Shimoni","year":"2001","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.virol.2005.02.020_bib60","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib61","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/JVI.76.8.3784-3790.2002","article-title":"Membrane interactions of the Tick-Borne Encephalitis virus fusion protein E at low pH","volume":"76","author":"Stiasny","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib62","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.virol.2005.02.020_bib63","doi-asserted-by":"crossref","first-page":"38755","DOI":"10.1074\/jbc.M402385200","article-title":"Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile Virus","volume":"279","author":"Volk","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.02.020_bib64","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2005.02.020_bib65","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/jvi.63.6.2521-2526.1989","article-title":"Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release","volume":"63","author":"Wengler","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2005.02.020_bib66","doi-asserted-by":"crossref","first-page":"46007","DOI":"10.1074\/jbc.M307776200","article-title":"Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2005.02.020_bib67","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2000.0795","article-title":"An infectious clone of the West Nile flavivirus","volume":"281","author":"Yamshchikov","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virol.2005.02.020_bib68","first-page":"2.5.2","article-title":"Production of monoclonal antibodies","volume":"vol. 1","author":"Yokoyama","year":"1994"},{"key":"10.1016\/j.virol.2005.02.020_bib69","doi-asserted-by":"crossref","first-page":"9168","DOI":"10.1021\/bi049324g","article-title":"Solution structure and structural dynamics of envelope protein domain III of mosquito- and tick-borne flaviviruses","volume":"43","author":"Yu","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.virol.2005.02.020_bib70","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682205001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:36:05Z","timestamp":1758584165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682205001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0042682205001418"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2005.02.020","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of neutralizing antibodies to West Nile virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2005.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}